Johnson & Johnson (JNJ) P/S (1999 - 2026)
Johnson & Johnson (JNJ) P/S from Nov 1, 1999 to Jul 20, 2026. The TTM Johnson & Johnson (JNJ) P/S is 6.22. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Johnson & Johnson (JNJ)
| Year | P/S | Change |
|---|---|---|
| 2026 | 6.22 | +17.60% |
| 2025 | 5.29 | +35.00% |
| 2024 | 3.92 | -28.12% |
| 2023 | 5.45 | -4.84% |
| 2022 | 5.73 | +16.36% |
| 2021 | 4.92 | -3.89% |
| 2020 | 5.12 | +9.38% |
| 2019 | 4.68 | +10.36% |
| 2018 | 4.24 | +3.58% |
| 2017 | 4.10 | -180.80% |
| 2015 | -5.07 | -105.35% |
| 2014 | 94.77 | +607.46% |
| 2013 | 13.40 | +134.42% |
| 2012 | 5.71 | +259.61% |
| 2008 | 1.59 | -4.69% |
| 2007 | 1.67 | +1.03% |
| 2006 | 1.65 | +9.85% |
| 2005 | 1.50 | -5.23% |
| 2004 | 1.59 | +22.76% |
| 2003 | 1.29 | -3.82% |
| 2002 | 1.34 | -9.12% |
| 2001 | 1.48 | +12.46% |
| 2000 | 1.31 | +12.71% |
| 1999 | 1.17 | N/A |
Comparison Johnson & Johnson (JNJ) P/S with competitors
Johnson & Johnson (JNJ) P/S is 6.22.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -90.76% |
| NVO | Novo Nordisk | 0.66 | -89.36% |
| GRFS | Grifols SA | 0.67 | -89.22% |
| AMRN | Amarin Corp | 1.39 | -77.66% |
| SCLX | Scilex Holding Company | 1.92 | -69.23% |
| SNY | Sanofi | 2.18 | -64.92% |
| PFE | Pfizer Inc | 2.18 | -64.92% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -61.45% |
| BIIB | Biogen Inc | 2.93 | -52.91% |
| GSK | GSK Plc | 3.22 | -48.19% |
| MRK | Merck & Co Inc | 4.54 | -27.10% |
| AZN | Astrazeneca plc | 4.58 | -26.32% |
| NVS | Novartis AG | 5.07 | -18.52% |
| AMGN | AMGEN Inc | 5.15 | -17.24% |
| GILD | Gilead Sciences Inc | 5.43 | -12.74% |
| ABBV | Abbvie Inc | 7.15 | +14.90% |
| LLY | Lilly(Eli) & Company | 14.28 | +129.49% |